Schwarz Karine, Villas-Bôas Anna Paula, Cielo Carla Aparecida, da Silva Dhiordan Carodoso, da Silva Eliane Dias, Fighera Tayane Muniz, Costa Angelo Brandelli, Lobato Maria Inês Rodrigues, Spritzer Poli Mara
Division of Endocrinology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.
Department of Psychiatry, Gender Identity Program at Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.
Front Public Health. 2024 Dec 16;12:1480423. doi: 10.3389/fpubh.2024.1480423. eCollection 2024.
The aim of this study was to adapt and apply the Portuguese version of the Transgender Man Voice Questionnaire in a sample of Brazilian transgender men and to investigate the relationship between voice satisfaction and hormone therapy duration. In addition, we suggest reducing and reformulating the questionnaire for screening.
We conducted a cross-sectional study of 31 transgender men aged 18-50 years undergoing hormone therapy who answered a questionnaire adapted from the Transgender Woman Voice Questionnaire, validated in Portuguese. Sociodemographic and clinical data were collected from the individuals' electronic medical records: age, smoking status, and type and duration of hormone therapy. The questionnaire, consisting of 30 questions rated on a Likert scale, was answered individually during a psychotherapy session. In each question, the gender-specific words were modified. Furthermore, we added a question: 31 (After GAHT, my voice became completely male), with the response options yes or no. In questions 32 and 33, asking participants to provide an overall rating of their voice. Total score ranged from 0 to 120, with higher scores indicating greater dissatisfaction with voice.
Mean patient age was 30.13 ± 7.6 years, and 19.4% were smokers. The mean duration of hormone therapy was 29.7 ± 24.9 months, and 95% received intramuscular testosterone cypionate, maintaining serum testosterone levels within the male reference range. The questionnaire mean total score was 51 ± 17.72. There was a significant negative correlation between the questionnaire total score and duration of hormone therapy ( = -0.484, = 0.006). The questionnaire had a high level of internal consistency/reliability, with a Cronbach's alpha coefficient of 0.95 for all items and a split-half Spearman-Brown coefficient of 0.96. For the elaboration of a screening tool, it is suggested to remove questions 8, 10, 12, 13, 14, 17, 19, 23, 27, and 29 and modify question 1.
Longer hormone therapy favors voice deepening and satisfaction with voice. The psychometric properties of the Transgender Man Voice Questionnaire are reliable, supporting its use as a screening tool in clinical practice and as an adjunct to the planning of vocal and communication support for transgender individuals.
本研究旨在对巴西跨性别男性样本改编并应用葡萄牙语版的跨性别男性嗓音问卷，并调查嗓音满意度与激素治疗持续时间之间的关系。此外，我们建议对问卷进行精简和重新设计以用于筛查。
我们对31名年龄在18至50岁之间正在接受激素治疗的跨性别男性进行了横断面研究，他们回答了一份改编自葡萄牙语验证版的跨性别女性嗓音问卷的问卷。从个体的电子病历中收集社会人口学和临床数据：年龄、吸烟状况以及激素治疗的类型和持续时间。该问卷由30个按李克特量表评分的问题组成，在心理治疗过程中由个体单独回答。在每个问题中，对特定性别的词汇进行了修改。此外，我们添加了一个问题：31（接受性别确认激素治疗后，我的嗓音完全变成了男性嗓音），回答选项为是或否。在问题32和33中，要求参与者对自己的嗓音给出总体评分。总分范围为0至120分，分数越高表明对嗓音的不满程度越高。
患者的平均年龄为30.13±7.6岁，19.4%为吸烟者。激素治疗的平均持续时间为29.7±24.9个月，95%的人接受了肌肉注射环丙孕酮睾酮，使血清睾酮水平维持在男性参考范围内。问卷的平均总分是51±17.72。问卷总分与激素治疗持续时间之间存在显著的负相关（r=-0.484，p=0.0
